American privately held health technology company
Theranos was a privately held health technology corporation, initially touted as a breakthrough technology company, but subsequently infamous for its false claims to have devised blood tests that only needed very small amounts of blood. Founded in 2003 by then-19-year-old Elizabeth Holmes, Theranos raised more than US$700 million from venture capitalists and private investors, resulting in a $10 billion valuation at its peak in 2013 and 2014. Investors and the media hyped Theranos as a breakthrough in the large blood-testing market, where the U.S. diagnostic-lab industry posts annual sales of over $70 billion. Theranos claimed its technology was revolutionary and that its tests required only about 1/100 to 1/1,000 of the amount of blood that would ordinarily be needed and cost far less than existing tests.
No news matches foundSorry, we were unable to find any results in our database for your query
Free news archive access
Did you know?
You are eligible to search our news archive with millions of news references free of charge.
To do this, please sign in first at the top of the screen.
• Information about free access to our news archive
Search this site and the web:
You Might Like